Anthropometric changes in patients receiving highly active antiretroviral therapy (ART)
Idiculla, J.
Journal of the Association of Physicians of India 59: 530; Author Reply 530
2011
ISSN/ISBN: 0004-5772 PMID: 21887919 Document Number: 653556
Document emailed within 1 workday
Related Documents
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Sevastianova, K.; Sutinen, J.; Westerbacka, J.; Ristola, M.; Yki-Järvinen, H. 2005: Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy Antiviral Therapy 10(8): 925-935
Sulaiman, M.M.; Shettima, J.; Ummate, I.; Arogundade, F.A.; Yusuph, H.; Nwankwo, E.; Sanusi, A.A.; Akinsola, A. 2022: Comparative Evaluation of Prevalence, Risk Factors, and Pathologic Features of Kidney Disease in Highly Active Antiretroviral Therapy-Naive and Highly Active Antiretroviral Therapy-Experienced Patients at a Tertiary Health Facility in Maiduguri, Northeastern Nigeria Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 33(1): 72-79
Pomerantz, R.J. 1999: HIV patients receiving HAART therapy can still transmit the virus. Highly active antiretroviral chemotherapy American Family Physician 59(10): 2855
Da Silva, C.A.L.; Dourado, I.ês.; Dahia, S.R.; Harzheim, E.; Rutherford, G.W. 2008: Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil Journal of Public Health Dentistry 68(3): 178-181
Bwana, V.; Tenu, F.; Magesa, S.M.; Mfinanga, S.G. 2011: Smear positive pulmonary tuberculosis among HIV patients receiving highly active antiretroviral therapy in Dar es Salaam, Tanzania Tanzania Journal of Health Research 13(1): 14-20
Girardi, E.; Sabin, C.A.; d'Arminio Monforte, A.; Hogg, B.; Phillips, A.N.; Gill, M.John.; Dabis, F.; Reiss, P.; Kirk, O.; Bernasconi, E.; Grabar, S.; Justice, A.; Staszewski, S.; Fätkenheuer, G.; Sterne, J.A.C. 2005: Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 41(12): 1772-1782
Chen, X.-j.; Yu, K.; Zhou, F. 2008: Analysis of pre-treatment screening on 160 HIV/AIDS patients receiving highly active antiretroviral therapy ( AZT +3TC + EFV) treatment Zhonghua Liu Xing Bing Xue Za Zhi 29(11): 1166-1167
Han, S.H.; Chin, B.S.; Choi, H.K.; Shin, S.Y.; Chae, Y.T.; Baek, J.-H.; Kim, C.O.; Choi, J.Y.; Song, Y.G.; Lee, H.C.; Kim, J.M. 2009: Prevalence of and clinical factors associated with lipoatrophy in HIV-infected Koreans receiving highly active antiretroviral therapy Tohoku Journal of Experimental Medicine 219(2): 145-153
Werner, M.L.F.; Pone, M.V.d.S.; Fonseca, V.ân.M.; Chaves, C.él.R.M.d.M. 2010: Lipodystrophy syndrome and cardiovascular risk factors in children and adolescents infected with HIV/AIDS receiving highly active antiretroviral therapy Jornal de Pediatria 86(1): 27-32
Werner, M.L.F.; Pone, M.V.d.S.; Fonseca, V.ân.M.; Chaves, C.él.R.M.d.M. 2010: Lipodystrophy syndrome and cardiovascular risk factors in children and adolescents infected with HIV/AIDS receiving highly active antiretroviral therapy Jornal de Pediatria 86(1): 27-32
Musoke, P.M.; Mudiope, P.; Barlow-Mosha, L.N.; Ajuna, P.; Bagenda, D.; Mubiru, M.M.; Tylleskar, T.; Fowler, M.G. 2010: Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study Bmc Pediatrics 10: 56
Lee, B.; Aurpibul, L.; Sirisanthana, V.; Mangklabruks, A.; Sirisanthana, T.; Puthanakit, T. 2009: Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand HIV Medicine 10(2): 72-78
Tan, R.; Westfall, A.O.; Willig, J.H.; Mugavero, M.J.; Saag, M.S.; Kaslow, R.A.; Kempf, M.C. 2008: Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 47(5): 553-558
Talukdar, A.; Ghosal, M.Kumar.; Sanyal, D.; Talukdar, P.Sengupta.; Guha, P.; Guha, S.Kamal.; Basu, S. 2013: Determinants of quality of life in HIV-infected patients receiving highly active antiretroviral treatment at a medical college ART center in Kolkata, India Journal of the International Association of Providers of AIDS Care 12(4): 284-290
Lertcheewakarn, P.; Tongprasert, F. 2014: A comparison of maternal anemia between HIV infected pregnant women receiving zidovudine-based and zidovudine-free highly active Antiretroviral therapy (HAART) Journal of the Medical Association of Thailand 97(4): 361-368
Deng, X.-j.; He, Y.; Yang, L.; Zou, S.-p.; Yang, H.; Zheng, Y.-h. 2011: The evaluation of four-year highly active antiretroviral therapy in HIV-1 infected patients Zhonghua Nei Ke Za Zhi 50(3): 230-234
Tiwari, B.R.; Karki, S.; Ghimire, P.; Sharma, B.; Malla, S. 2013: Improvement in immunological parameters in patients receiving highly active anti-retroviral therapy in Nepal Japanese Journal of Infectious Diseases 66(3): 252-255
Fox, R.; Gourlay, Y.J. 2000: The impact of highly active antiretroviral combination therapy in HIV infected patients in Glasgow Health Bulletin 58(4): 309-315